Phibro Animal Health (PAHC) Operating Income (2012 - 2026)

Phibro Animal Health has reported Operating Income for 15 years, with the latest figure at $48.2 million in Q2 2026.

• On a quarterly basis, Operating Income rose 42.82% year-over-year to $48.2 million in Q2 2026; TTM through Jun 2026 was $194.4 million, a 75.98% increase from a year earlier, with the FY2026 full-year figure at $194.4 million, up 75.98% from the prior year.
• Operating Income was $48.2 million for Q2 2026 at Phibro Animal Health, up from $44.7 million in the prior quarter.
• The five-year high for Operating Income was $51.3 million in Q3 2025, with the low at -$726000.0 in Q3 2023.
• Average Operating Income over 5 years is $26.2 million, with a median of $21.4 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Operating Income tumbled 105.31% in 2023, then soared 2537.88% in 2024.
• Over 5 years, Operating Income stood at $15.8 million in 2022, then fell by 0.9% to $15.7 million in 2023, then surged by 62.62% to $25.5 million in 2024, then soared by 97.1% to $50.3 million in 2025, then slipped by 4.31% to $48.2 million in 2026.
• The last three Operating Income figures came in at $48.2 million (Q2 2026), $44.7 million (Q1 2026), and $50.3 million (Q4 2025), per Business Quant data.